Prothena Corp Public Ltd Co SEC filings PRTA

Prothena Corp Public Ltd Co has 1,006 filings in SEC EDGAR's recent list, going back to Jan 31, 2013. Its latest annual report, Form ARS, was filed on Mar 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Prothena Corp Public Ltd Co SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
8-K Current report
Agreement ended
Oct 29, 2026 Oct 28, 2026
8-K Current report
Officer or director change
Oct 2, 2026 Oct 2, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
8-K Current report
Shareholder vote results
May 15, 2026 May 14, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
ARS Annual report to shareholders Mar 27, 2026 Dec 31, 2025
DEFA14A Additional proxy material Mar 27, 2026 —
DEF 14A Proxy statement Mar 27, 2026 May 14, 2026
EFFECT Filing Mar 2, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Feb 27, 2026 Feb 27, 2026
POS AM Filing Feb 27, 2026 —
10-K Annual report Feb 27, 2026 Dec 31, 2025
POSASR Filing Feb 27, 2026 —
8-K Current report
Results of operations
Feb 19, 2026 Feb 19, 2026
8-K Current report
Officer or director change
Dec 12, 2025 Dec 10, 2025
8-K Current report
Shareholder vote results
Nov 19, 2025 Nov 19, 2025
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
DEFA14A Additional proxy material Nov 6, 2025 —
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
DEFA14A Additional proxy material Oct 7, 2025 —
DEF 14A Proxy statement Oct 7, 2025 Nov 19, 2025
PRE 14A Preliminary proxy statement Sep 25, 2025 Nov 19, 2025
8-K Current report
Other events
Aug 27, 2025 Aug 27, 2025
S-8 Employee stock plan registration Aug 8, 2025 —
8-K Current report
Other events
Aug 6, 2025 Aug 6, 2025
10-Q Quarterly report Aug 4, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 4, 2025 Aug 4, 2025
8-K Current report
Officer or director change
Jul 30, 2025 Jul 30, 2025
8-K Current report
Exit or restructuring costs, Officer or director change
Jun 18, 2025 Jun 13, 2025
8-K Current report
Other events
Jun 16, 2025 Jun 15, 2025
8-K Current report
Other events
May 23, 2025 May 23, 2025
8-K Current report
Officer or director change, Shareholder vote results
May 16, 2025 May 13, 2025
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
ARS Annual report to shareholders Mar 28, 2025 Dec 31, 2024
DEFA14A Additional proxy material Mar 28, 2025 —
DEF 14A Proxy statement Mar 28, 2025 May 13, 2025
10-K Annual report Feb 27, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 20, 2025 Feb 20, 2025
8-K Current report
Officer or director change
Dec 30, 2024 Dec 29, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 27, 2024 Sep 23, 2024
S-8 Employee stock plan registration Aug 8, 2024 —
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
8-K Current report
Material agreement, Other events
May 28, 2024 May 24, 2024
8-K Current report
Officer or director change, Shareholder vote results
May 17, 2024 May 14, 2024
10-Q Quarterly report May 8, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 8, 2024 May 8, 2024
ARS Annual report to shareholders Mar 29, 2024 Dec 31, 2023
DEFA14A Additional proxy material Mar 29, 2024 —
DEF 14A Proxy statement Mar 29, 2024 May 14, 2024
S-3ASR Automatic shelf registration Feb 22, 2024 —
10-K Annual report Feb 22, 2024 Dec 31, 2023
8-K Current report
Officer or director change
Feb 21, 2024 Feb 21, 2024
8-K Current report
Results of operations
Feb 15, 2024 Feb 15, 2024
8-K Current report
Results of operations, Other events
Jan 8, 2024 Jan 8, 2024
10-Q Quarterly report Nov 2, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 2, 2023 Nov 2, 2023
UPLOAD Letter from the SEC Aug 23, 2023 —
CORRESP Letter to the SEC Aug 4, 2023 —
S-8 Employee stock plan registration Aug 3, 2023 —
10-Q Quarterly report Aug 3, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 3, 2023 Aug 3, 2023
UPLOAD Letter from the SEC Jul 25, 2023 —
8-K Current report
Material agreement
Jul 10, 2023 Jul 5, 2023
8-K Current report
Officer or director change, Shareholder vote results
May 19, 2023 May 16, 2023
8-K Current report
Officer or director change
May 16, 2023 May 16, 2023
10-Q Quarterly report May 4, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 4, 2023 May 4, 2023
8-K Current report
Officer or director change
Apr 28, 2023 Apr 25, 2023
ARS Annual report to shareholders Mar 31, 2023 Dec 31, 2022
DEFA14A Additional proxy material Mar 31, 2023 —
DEF 14A Proxy statement Mar 31, 2023 —
8-K Current report
Regulation FD disclosure
Mar 10, 2023 Mar 10, 2023
10-K Annual report Feb 28, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 23, 2023 Feb 23, 2023
8-K Current report
Other events
Dec 16, 2022 Dec 14, 2022
424B5 Prospectus supplement Dec 16, 2022 —
424B5 Prospectus supplement Dec 13, 2022 —
8-K Current report
Other events
Nov 21, 2022 Nov 21, 2022
10-Q Quarterly report Nov 3, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 3, 2022 Nov 3, 2022
8-K Current report
Material agreement
Oct 31, 2022 Oct 28, 2022
8-K Current report
Officer or director change
Sep 1, 2022 Aug 30, 2022
S-8 Employee stock plan registration Aug 10, 2022 —
10-Q Quarterly report Aug 8, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 8, 2022 Aug 8, 2022
8-K Current report
Officer or director change, Shareholder vote results
May 20, 2022 May 17, 2022
10-Q Quarterly report May 5, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 5, 2022 May 5, 2022
DEFA14A Additional proxy material May 5, 2022 —
8-K Current report
Other events
Apr 26, 2022 Apr 26, 2022
DEFA14A Additional proxy material Apr 25, 2022 —
DEFA14A Additional proxy material Mar 31, 2022 —
DEF 14A Proxy statement Mar 31, 2022 May 17, 2022
8-K Current report
Regulation FD disclosure
Mar 28, 2022 Mar 28, 2022
8-K Current report
Regulation FD disclosure
Mar 25, 2022 Mar 25, 2022
PRE 14A Preliminary proxy statement Mar 11, 2022 May 17, 2022
10-K Annual report Feb 25, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 17, 2022 Feb 17, 2022
8-K Current report
Other events
Dec 23, 2021 Dec 23, 2021
424B5 Prospectus supplement Dec 23, 2021 —
10-Q Quarterly report Nov 4, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 4, 2021 Nov 4, 2021
8-K Current report
Officer or director change
Oct 1, 2021 Sep 29, 2021
S-8 Employee stock plan registration Aug 6, 2021 —
10-Q Quarterly report Aug 5, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 5, 2021 Aug 5, 2021
8-K Current report
Material agreement
Aug 3, 2021 Jul 30, 2021
8-K Current report
Material agreement, Regulation FD disclosure
Jul 12, 2021 Jul 8, 2021
8-K Current report
Other events
Jun 24, 2021 Jun 24, 2021
8-K Current report
Other events
May 28, 2021 May 28, 2021
424B5 Prospectus supplement May 28, 2021 —
8-K Current report
Other events
May 28, 2021 May 28, 2021
8-K Current report
Officer or director change, Shareholder vote results
May 21, 2021 May 18, 2021
8-K Current report
Officer or director change
May 20, 2021 May 18, 2021
10-Q Quarterly report May 11, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 11, 2021 May 11, 2021
CT ORDER Filing Apr 20, 2021 —
DEFA14A Additional proxy material Mar 31, 2021 —
DEF 14A Proxy statement Mar 31, 2021 May 18, 2021
8-K Current report
Other events
Mar 26, 2021 Mar 23, 2021
424B5 Prospectus supplement Mar 24, 2021 —
424B5 Prospectus supplement Mar 23, 2021 —
S-3ASR Automatic shelf registration Mar 23, 2021 —
PRE 14A Preliminary proxy statement Mar 15, 2021 May 18, 2021
10-K Annual report Feb 26, 2021 Dec 31, 2020
SC TO-I/A Amendment no. 5 to sc to-i Feb 16, 2021 —
8-K Current report
Results of operations
Feb 11, 2021 Feb 11, 2021
SC TO-I/A Amendment no. 4 to sc to-i Feb 5, 2021 —
8-K Current report
Other events
Feb 1, 2021 Feb 1, 2021
SC TO-I/A Amendment no. 3 to sc to-i Jan 28, 2021 —
SC TO-I/A Amendment no. 2 to sc to-i Jan 21, 2021 —
8-K Current report
Other events
Dec 9, 2020 Dec 9, 2020
SC TO-I/A Amendment no. 1 to sc to-i Dec 4, 2020 —
SC TO-I Filing Nov 9, 2020 —
10-Q Quarterly report Nov 4, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 4, 2020 Nov 4, 2020
8-K Current report
Other events
Oct 20, 2020 Oct 20, 2020
S-8 Employee stock plan registration Aug 11, 2020 —
10-Q Quarterly report Aug 6, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 6, 2020 Aug 6, 2020
8-K Current report
Officer or director change, Shareholder vote results
May 22, 2020 May 19, 2020
10-Q Quarterly report May 6, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 6, 2020 May 6, 2020
DEFA14A Additional proxy material Apr 24, 2020 —
DEFA14A Additional proxy material Mar 25, 2020 —
DEF 14A Proxy statement Mar 25, 2020 May 19, 2020
PRE 14A Preliminary proxy statement Mar 12, 2020 May 19, 2020
10-K Annual report Mar 3, 2020 Dec 31, 2019
8-K Current report
Results of operations
Feb 12, 2020 Feb 12, 2020
8-K Current report
Other events
Dec 19, 2019 Dec 19, 2019
EFFECT Filing Dec 12, 2019 —
CORRESP Letter to the SEC Dec 10, 2019 —
8-K Current report
Officer or director change
Dec 5, 2019 Dec 3, 2019
S-3/A Amendment no. 1 to form s-3 Nov 27, 2019 —
10-Q Quarterly report Nov 5, 2019 Sep 30, 2019
8-K Current report
Results of operations
Nov 5, 2019 Nov 5, 2019
8-K/A Amended current report
Officer or director change
Oct 30, 2019 Oct 29, 2019
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 24, 2019 Sep 24, 2019
8-K/A Amended current report
Officer or director change
Sep 20, 2019 Sep 18, 2019
10-Q Quarterly report Aug 6, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 6, 2019 Aug 6, 2019
UPLOAD Letter from the SEC Jul 31, 2019 —
CT ORDER Filing Jul 12, 2019 —
8-K Current report
Officer or director change
Jul 3, 2019 Jul 1, 2019
CORRESP Letter to the SEC Jun 26, 2019 —
CORRESP Letter to the SEC Jun 18, 2019 —
CORRESP Letter to the SEC Jun 7, 2019 —
UPLOAD Letter from the SEC May 29, 2019 —
UPLOAD Letter from the SEC May 29, 2019 —
8-K Current report
Shareholder vote results
May 24, 2019 May 21, 2019
S-3 Shelf registration May 22, 2019 —
10-Q Quarterly report May 7, 2019 Mar 31, 2019
8-K Current report
Results of operations
May 7, 2019 May 7, 2019
8-K Current report
Other events
Apr 18, 2019 Apr 18, 2019
CORRESP Letter to the SEC Apr 17, 2019 —
UPLOAD Letter from the SEC Apr 4, 2019 —
DEFA14A Additional proxy material Mar 28, 2019 —
DEF 14A Proxy statement Mar 28, 2019 May 21, 2019
CT ORDER Filing Mar 28, 2019 —
10-K Annual report Mar 15, 2019 Dec 31, 2018
CORRESP Letter to the SEC Feb 28, 2019 —
8-K Current report
Results of operations
Feb 14, 2019 Feb 14, 2019
CORRESP Letter to the SEC Jan 22, 2019 —
CORRESP Letter to the SEC Jan 3, 2019 —
UPLOAD Letter from the SEC Dec 19, 2018 —
8-K Current report
Officer or director change
Dec 14, 2018 Dec 11, 2018
10-Q Quarterly report Nov 6, 2018 Sep 30, 2018
8-K Current report
Results of operations
Nov 6, 2018 Nov 6, 2018
8-K Current report
Material agreement
Sep 28, 2018 Sep 24, 2018
CT ORDER Filing Aug 22, 2018 —
10-Q/A Amended quarterly report Aug 17, 2018 Mar 31, 2018
S-8 Employee stock plan registration Aug 9, 2018 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
PRTA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Ireland
Headquarters
Dublin 2, Ireland
SEC filer status
Accelerated filer
SEC CIK
1559053
Former names
Prothena Corp plc (until May 22, 2020); Neotope Corp Ltd (until Oct 1, 2012)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.